A Reversal for AIDA PHARMACEUTICALS INC (OTCMKTS:AIDA) Is Not Near. The Stock Has Rise in Shorts

June 17, 2018 - By Peter Erickson

The stock of AIDA PHARMACEUTICALS INC (OTCMKTS:AIDA) registered an increase of 50% in short interest. AIDA’s total short interest was 300 shares in June as published by FINRA. Its up 50% from 200 shares, reported previously. With 3,000 shares average volume, it will take short sellers 0 days to cover their AIDA’s short positions.

It closed at $0.02 lastly. It is down 0.00% since June 17, 2017 and is . It has underperformed by 12.57% the S&P500.

Aida Pharmaceuticals, Inc., together with its subsidiaries, engages in the formulation, clinical testing, registration, manufacture, sales, and marketing of pharmaceutical and genetic products in mainland China. The company has market cap of $540,000. It offers antibiotics, cardiovascular, and anti-cancer drugs. It currently has negative earnings. The firm provides its products in the form of powder for injection; and liquid for intravenous injection, capsule, tablet, and ointment.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.